Cantel Medical Insights: Return On Capital Employed
Looking at Q3, Cantel Medical (NYSE: CMD ) earned $45.52 million, a 43.93% increase from the preceding quarter. Cantel Medical also posted a total of $313.95 million in sales, a 6.77% increase since Q2. Cantel Medical earned $31.63 million, and sales totaled $294.04 million in Q2. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative Full story available on Benzinga.com
Cantel Medical Insights: Return On Capital Employed
Looking at Q3, Cantel Medical (NYSE: CMD ) earned $45.52 million, a 43.93% increase from the preceding quarter. Cantel Medical also posted a total of $313.95 million in sales, a 6.77% increase since Q2. Cantel Medical earned $31.63 million, and sales totaled $294.04 million in Q2. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative Full story available on Benzinga.com